Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.70
-0.29 (-3.23%)
At close: Apr 28, 2026, 4:00 PM EDT
8.70
0.00 (0.00%)
Pre-market: Apr 29, 2026, 7:28 AM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $526.61 million as of April 29, 2026. Its market cap has increased by 551.65% in one year.
Market Cap
526.61M
Enterprise Value
276.39M
1-Year Change
551.65%
Ranking
Category
Stock Price
$8.70
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $526.61M, a decrease of -41.36%. That is a compound annual growth rate of -21.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 544.17M | 1.33% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 561.94M |
| Rigel Pharmaceuticals | 559.76M |
| Altimmune | 553.47M |
| Sutro Biopharma | 552.19M |
| AgomAb Therapeutics NV | 538.54M |
| Tectonic Therapeutic | 535.88M |
| enGene Therapeutics | 535.25M |
| Lyell Immunopharma | 522.79M |